Register | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

philill's library [50 articles]

Recent papers added to philill's library.
  • A yoga intervention for young adults with elevated symptoms of depression.
    Altern Ther Health Med, Vol. 10, No. 2. (r 2004), pp. 60-63.
    by A Woolery, H Myers, B Sternlieb, L Zeltzer
    posted to awesome depression yoga by philill on 2008-01-15 17:54:55 as **
  • CD40 activation: potential for specific immunotherapy in B-CLL.
    Ann Oncol, Vol. 15, No. 6. (June 2004), pp. 853-857.
    by M von Bergwelt-Baildon, B Maecker, J Schultze, JG Gribben
    posted to activation cd40 cll immunotherapy by philill on 2007-07-20 10:06:35 as **
  • Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
    Semin Oncol, Vol. 33, No. 2. (April 2006), pp. 220-229.
    by R Le Dieu, J Gribben
    posted to cll immunotherapy review by philill on 2007-07-18 11:25:23 as **
  • Clinical staging of chronic lymphocytic leukemia.
    Blood, Vol. 46, No. 2. (August 1975), pp. 219-234.
    by KR Rai, A Sawitsky, EP Cronkite, AD Chanana, RN Levy, BS Pasternack
    posted to cll katja klassifikation by philill on 2007-04-20 08:32:47 as **
  • A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.
    Cancer, Vol. 48, No. 1. (1 July 1981), pp. 198-206.
    by JL Binet, A Auquier, G Dighiero, C Chastang, H Piguet, J Goasguen, G Vaugier, G Potron, P Colona, F Oberling, M Thomas, G Tchernia, C Jacquillat, P Boivin, C Lesty, MT Duault, M Monconduit, S Belabbes, F Gremy
    posted to cll katja klassifikation by philill on 2007-04-20 08:31:46 as **
  • Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma.
    Int J Cancer, Vol. 119, No. 6. (15 September 2006), pp. 1377-1382.
    by M Kornacker, G Moldenhauer, M Herbst, E Weilguni, F Tita-Nwa, C Harter, M Hensel, AD Ho
    posted to autologous cik cll ifn-gamma by philill on 2007-04-03 12:19:42 as **
  • Rapid expansion of allospecific cytotoxic T cell clones using nonspecific feeder cell lines without further addition of exogenous IL2.
    Transplantation, Vol. 38, No. 4. (October 1984), pp. 401-406.
    by RJ van de Griend, RL Bolhuis
    posted to cytoxicity il2 mlr t-cell by philill on 2007-04-03 09:59:27 as **
  • Variation in accessory cell requirements in human mixed lymphocyte response to leukaemic cell lines.
    Immunology, Vol. 47, No. 4. (December 1982), pp. 633-641.
    by D O'Keefe, L Ashman
    posted to cell leukemia lines mlr by philill on 2007-04-03 09:48:03 as **
  • Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells.
    Cytotherapy, Vol. 4, No. 2. (2002), pp. 165-175.
    by P Han, C Story, T McDonald, K Mrozik, L Snell
    posted to all dc-like mlr by philill on 2007-04-03 09:31:49 as **
  • A new mathematical model for relative quantification in real-time RT-PCR.
    Nucleic Acids Res, Vol. 29, No. 9. (1 May 2001)
    by MW Pfaffl
    posted to quantification realtime rtq-pcr by philill on 2006-12-18 12:46:20 as ** along with 5 people and 1 group imouthesmp dayjm cottrell natstreet endo_anaphy2 Jarman Lab
  • Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.
    Int J Hematol, Vol. 80, No. 1. (July 2004), pp. 52-58.
    by K Sugahara, A Uemura, H Harasawa, H Nagai, Y Hirakata, M Tomonaga, K Murata, H Sohda, T Nakagoe, S Shibasaki, Y Yamada, S Kamihira
    posted to leukemia neoplasm survivin by philill on 2006-12-07 15:06:57 as **
  • Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Leuk Res, Vol. 28, No. 5. (May 2004), pp. 487-494.
    by Y Nakagawa, S Yamaguchi, M Hasegawa, T Nemoto, M Inoue, K Suzuki, K Hirokawa, M Kitagawa
    posted to all cll survivin by philill on 2006-12-07 15:06:18 as *****
  • Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells.
    Blood, Vol. 106, No. 9. (1 November 2005), pp. 3223-3226.
    by C Mayr, DM Kofler, H Büning, D Bund, M Hallek, CM Wendtner
    posted to cd40-ligand cll t-cell by philill on 2006-12-07 14:42:18 as ** along with 1 person eisei
  • mRNA expression of tumor associated antigens in patients with chronic lymphocytic leukemia
    (2005^^^^)
    by K Giannopoulos
    posted to cll mrna taa by philill on 2006-12-07 14:39:36 as **
  • Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.
    Int J Oncol, Vol. 29, No. 1. (July 2006), pp. 95-103.
    by K Giannopoulos, L Li, A Bojarska-Junak, J Rolinski, A Dmoszynska, I Hus, J Greiner, C Renner, H Döhner, M Schmitt
    posted to b-cll cll fmod rhamm survivin taa by philill on 2006-12-07 14:28:47 as **
  • Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia.
    Leuk Lymphoma, Vol. 47, No. 10. (October 2006), pp. 2028-2036.
    by K Giannopoulos, M Schmitt
    posted to b-cll fmod survivin tcl vaccine by philill on 2006-12-07 14:27:25 as **
  • Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia.
    Blood, Vol. 97, No. 9. (1 May 2001), pp. 2777-2783.
    by L Granziero, P Ghia, P Circosta, D Gottardi, G Strola, M Geuna, L Montagna, P Piccoli, M Chilosi, F Caligaris-Cappio
    posted to b-cll cd40 cll survivin by philill on 2006-12-05 09:08:05 as **
  • Localization of the human fibromodulin gene (FMOD) to chromosome 1q32 and completion of the cDNA sequence.
    Genomics, Vol. 23, No. 3. (October 1994), pp. 715-717.
    by R Sztrolovics, XN Chen, J Grover, PJ Roughley, JR Korenberg
    posted to cloning fibromodulin fmod gene-location by philill on 2006-12-04 12:26:25 as **
  • Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
    Blood, Vol. 105, No. 12. (15 June 2005), pp. 4828-4835.
    by Eva Mikaelsson, Amir H Danesh-Manesh, Alfred Luppert, Mahmood Jeddi-Tehrani, Mohammad-Reza Rezvany, Ramazan A Sharifian, Reza Safaie, Azam Roohi, Anders Osterborg, Fazel Shokri, Hakan Mellstedt, Hodjattallah Rabbani
    posted to b-cll cll fibromodulin by philill on 2006-12-01 11:04:39 as **
  • The CD40 antigen and its ligand.
    Annu Rev Immunol, Vol. 12 (1994), pp. 881-922.
    by J Banchereau, F Bazan, D Blanchard, F Brière, JP Galizzi, C van Kooten, YJ Liu, F Rousset, S Saeland
    posted to cd40 cd40-ligand review by philill on 2006-11-21 16:16:30 as **
  • The dendritic cell system and its role in immunogenicity.
    Annu Rev Immunol, Vol. 9 (1991), pp. 271-296.
    by RM Steinman
    posted to dc immunogenicity by philill on 2006-11-21 16:08:59 as **
  • Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain.
    Cancer Immunol Immunother, Vol. 54, No. 11. (November 2005), pp. 1106-1114.
    by G Xiaoling, L Ying, L Jing, L Huifang, Z Xia, F Qingqing, Z Ping
    posted to b-cll ctl immunoglobulin ldh by philill on 2006-11-21 15:52:23 as **
  • Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotictumor lysate
    Leukemia and Lymphoma, Vol. 47, No. 2. (February 2006), pp. 297-306.
    by Kalathil Suresh, Graeme Fraser, Elizabeth Scheid, Brian Leber, Jack Gauldie, Ronan Foley
    posted to b-cll dc chromium ctl by philill on 2006-11-21 15:46:52 as **
  • Cytotoxic T cell responses against immunoglobulin in malignant and normal B cells: implications for tumor immunity and autoimmunity.
    Curr Pharm Des, Vol. 9, No. 23. (2003), pp. 1889-1903.
    by CS Gricks, JG Gribben
    posted to autoimmunity b-cell b-cll ctl immunity immunoglobulin by philill on 2006-11-21 15:37:22 as **
  • Identification of novel survivin-derived CTL epitopes.
    Cancer Biol Ther, Vol. 3, No. 2. (February 2004), pp. 173-179.
    by S Reker, A Meier, L Holten-Andersen, IM Svane, JC Becker, P thor Straten, MH Andersen
    posted to ctl epitope survivin by philill on 2006-11-17 21:06:17 as **
  • Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients.
    Cancer Res, Vol. 61, No. 3. (1 February 2001), pp. 869-872.
    by MH Andersen, LO Pedersen, JC Becker, PT Straten
    posted to ctl survivin by philill on 2006-11-17 21:03:19 as **
  • Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients.
    Cancer Res, Vol. 61, No. 16. (15 August 2001), pp. 5964-5968.
    by MH Andersen, LO Pedersen, B Capeller, EB Bröcker, JC Becker, P thor Straten
    posted to class1 ctl mhc survivin by philill on 2006-11-17 21:01:35 as **
  • Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia
    British Journal of Haematology, Vol. 129, No. 4. (May 2005), pp. 499-510.
    by Katja Mauerer, David Zahrieh, Gullu Gorgun, Aihong Li, Jianbiao Zhou, Sascha Ansen, Laura Z Rassenti, John G Gribben
    posted to b-cll cll immunogenicity immunoglobulin by philill on 2006-11-17 20:58:00 as **
  • Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.
    Blood, Vol. 96, No. 8. (15 October 2000), pp. 2655-2663.
    by JA Burger, N Tsukada, M Burger, NJ Zvaifler, M Dell'Aquila, TJ Kipps
    posted to apoptosis b-cll sdf1 stroma by philill on 2006-11-17 20:53:37 as **
  • Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.
    Blood, Vol. 94, No. 11. (1 December 1999), pp. 3658-3667.
    by JA Burger, M Burger, TJ Kipps
    posted to b-cll cll cxcr4 migration stroma by philill on 2006-11-17 20:51:25 as **
  • CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease.
    Ann Hematol, Vol. 82, No. 8. (August 2003), pp. 500-505.
    by J Barretina, J Juncà, A Llano, A Gutiérrez, A Flores, J Blanco, B Clotet, JA Esté
    posted to b-cll cxcr4 sdf1 by philill on 2006-11-17 20:49:28 as **
  • Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
    Cancer Res, Vol. 61, No. 13. (1 July 2001), pp. 5145-5152.
    by CS Gricks, E Rawlings, L Foroni, JA Madrigal, PL Amlot
    posted to b-cll ctl immunoglobulin mhc by philill on 2006-11-17 20:47:00 as **
  • ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    N Engl J Med, Vol. 351, No. 9. (26 August 2004), pp. 893-901.
    by LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, DS Neuberg, IW Flinn, KR Rai, JC Byrd, NE Kay, A Greaves, A Weiss, TJ Kipps
    posted to cll immunoglobulin zap-70 by philill on 2006-11-17 20:44:32 as **
  • Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies.
    Nat Med, Vol. 6, No. 6. (June 2000), pp. 667-672.
    by A Trojan, JL Schultze, M Witzens, RH Vonderheide, M Ladetto, JW Donovan, JG Gribben
    posted to b-cell ctl immunoglobulin immunotherapy by philill on 2006-11-17 20:40:13 as **
  • notes A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry.
    J Immunol Methods, Vol. 170, No. 2. (15 April 1994), pp. 145-157.
    by I Schmid, CH Uittenbogaart, B Keld, JV Giorgi
    posted to 7-aad apoptosis ctl facs by philill on 2006-11-17 20:38:40 as **
  • Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells.
    Eur J Immunol, Vol. 34, No. 6. (June 2004), pp. 1551-1560.
    by D Zehn, CJ Cohen, Y Reiter, P Walden
    posted to apc dc epitope by philill on 2006-11-17 20:36:54 as **
  • Cytotoxic T-cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide.
    Blood (10 August 2006)
    by Katja Mauerer M Zirlik, David Zahrieh, Donna Neuberg, John G G Gribben
    posted to cll ctl heteroclitic by philill on 2006-11-17 15:27:49 as ** along with 1 person eisei
  • Novel immune-based treatment strategies for chronic lymphocytic leukemia.
    J Clin Oncol, Vol. 23, No. 26. (10 September 2005), pp. 6325-6332.
    by WG Wierda, TJ Kipps, MJ Keating
    posted to cll immunotherapy review by philill on 2006-11-17 15:23:28 as **
  • Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    Nat Med (19 March 2006)
    by Thorbald van Hall, Elisabeth Z Z Wolpert, Peter van Veelen, Sandra Laban, Michael van der Veer, Marjet Roseboom, Sandra Bres, Per Grufman, Arnoud de Ru, Hugo Meiring, Ad de Jong, Kees Franken, Antoinette Teixeira, Rob Valentijn, Jan Wouter W Drijfhout, Frits Koning, Marcel Camps, Ferry Ossendorp, Klas Kärre, Hans-Gustaf G Ljunggren, Cornelis J M J Melief, Rienk Offringa
    posted to ctl t-cell taa tap by philill on 2006-11-17 15:20:51 as ** along with 2 people kentsis eisei
  • Chronic lymphocytic leukemia.
    N Engl J Med, Vol. 352, No. 8. (24 February 2005), pp. 804-815.
    by N Chiorazzi, KR Rai, M Ferrarini
    posted to cll nejm review by philill on 2006-11-17 15:17:08 as **
  • CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
    Blood, Vol. 107, No. 5. (1 March 2006), pp. 1761-1767.
    by JA Burger, TJ Kipps
    posted to cxcr4 stroma tumor by philill on 2006-11-17 15:12:56 as ** along with 1 person eisei
  • Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells.
    Blood (25 May 2004)
    by Clair S S Gricks, David Zahrieh, A J J Zauls, Gullu Gorgun, Daniela Drandi, Katja Mauerer, Donna Neuberg, John G G Gribben
    posted to 40 b-cell b-cll cd expression gene by philill on 2006-11-08 17:58:34 as ** along with 1 person hubcite
  • Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes.
    Blood, Vol. 105, No. 4. (15 February 2005), pp. 1566-1573.
    by C Mayr, D Bund, M Schlee, A Moosmann, DM Kofler, M Hallek, CM Wendtner
    posted to cll ctl fibromodulin fmod survivin taa by philill on 2006-11-03 10:23:24 as ** along with 1 person eisei
  • T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil
    Cancer Immunology, Immunotherapy, Vol. V55, No. 2. (12 February 2006), pp. 210-220.
    by Hã¥kan Mellstedt, Aniruddha Choudhury
    posted to b-cell b-cll cll t-cell by philill on 2006-11-03 10:15:51 as **
  • An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
    Clin Cancer Res, Vol. 8, No. 6. (June 2002), pp. 1731-1739.
    by Y Hirohashi, T Torigoe, A Maeda, Y Nabeta, K Kamiguchi, T Sato, J Yoda, H Ikeda, K Hirata, N Yamanaka, N Sato
    posted to ctl hla-a24 survivin by philill on 2006-11-03 10:13:05 as **
  • Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule.
    Cancer Res, Vol. 61, No. 12. (15 June 2001), pp. 4761-4765.
    by A Trojan, M Witzens, JL Schultze, RH Vonderheide, S Harig, AM Krackhardt, RA Stahel, JG Gribben
    posted to cll ctl immunoglobulin by philill on 2006-11-03 10:04:00 as **
  • Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues.
    Blood, Vol. 98, No. 10. (15 November 2001), pp. 2999-3005.
    by S Harig, M Witzens, AM Krackhardt, A Trojan, P Barrett, R Broderick, AJ Zauls, JG Gribben
    posted to ctl hla-a2 immunoglobulin by philill on 2006-11-03 10:03:30 as **
  • T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
    Blood, Vol. 100, No. 1. (1 July 2002), pp. 167-173.
    by AM Krackhardt, S Harig, M Witzens, R Broderick, P Barrett, JG Gribben
    posted to cll ctl immunotherapy by philill on 2006-11-03 10:02:55 as **
  • Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
    Blood, Vol. 106, No. 5. (1 September 2005), pp. 1824-1830.
    by M Burger, T Hartmann, M Krome, J Rawluk, H Tamamura, N Fujii, TJ Kipps, JA Burger
    posted to b-cll cd184 cll cxcl12 cxcr4 by philill on 2006-11-03 09:08:51 as ***
  • Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.
    Blood, Vol. 102, No. 2. (15 July 2003), pp. 571-576.
    by SM Schmidt, K Schag, MR Müller, MM Weck, S Appel, L Kanz, F Grünebach, P Brossart
    posted to ctl survivin taa by philill on 2006-09-08 15:03:31 as read
    • Note: You may cite this page as: http://www.citeulike.org/user/philill

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.